The future of the global mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets. The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the mRNA vaccine market by
type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA
vaccines), application (cancer immunotherapy, allergy tolerization, and
therapeutic vaccines), end use (hospitals & clinics, research laboratories,
and others), and region (North America, Europe, Asia Pacific, and the Rest of
the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will
grow at a faster pace and why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging
trends in this market and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, cancer
immunotherapy, allergy tolerization, and therapeutic vaccines are the major
segments of mRNA vaccine market by application. Lucintel forecasts that cancer
immunotherapy is expected to witness highest growth over the forecast period.
Within this market,
hospital & clinic will remain the largest segment due to growing patients
preference for this facilities because of the convenient access to
vaccinations, availability of trained medical personnel, and existence of
advanced healthcare infrastructure.
North America will
remain the largest regiondue to augmenting prevalence of infectious diseases
among population, existence of robust healthcare infrastructure, and presence
of key players in the region.
Pfizer, Moderna,
BioNTech, GlaxoSmithKline, and Daiichi Sankyo are the major suppliers in the mRNA
vaccine market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
10. Stretcher Market
No comments:
Post a Comment